On the contrary, BAPTA-AM had opposite effects on two EMT transcription factors- it increased levels of TWIST1, but decreased the EGF- induced expression of SNAI1, a factor associated with decreased relapse-free survival in women with breast cancer [11]. The gene discussed is EGF; the disease is breast cancer.